Berlin Named to New VICC Leadership Post
Published: Thursday, July 12, 2018 3:53 pm
Jordan Berlin, MD, has been named associate director of Clinical Investigation Strategy and Shared Resources at the Vanderbilt-Ingram Cancer Center (VICC). In his new role, he will chair the Resource Allocation Committee and continue as chair of the Clinical Trials Shared Resource (CTSR) Steering Committee.
Berlin is an Ingram Professor of Cancer Research, and co-leader of the Gastrointestinal Cancer Research Program and director of the Phase 1 Clinical Trials Program at VICC. He received his medical degree from the University of Illinois, Chicago, and completed an internship and residency in Internal Medicine at the University of Cincinnati Hospital. He completed a fellowship in Medical Oncology at the University of Wisconsin Hospital and Clinics, in Madison and later became a faculty member. Berlin joined the faculty at Vanderbilt in 1999 and is co-director of the Administrative Core for Vanderbilt's GI Specialized Program of Research Excellence (SPORE), a prestigious research grant program funded by the National Cancer Institute (NCI).